🔎 Trials Near Me

Home › Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma clinical trials recruiting in the U.S.

13 studies for Nasopharyngeal Carcinoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

RecruitingPhase 2
Up to age 21 · All sexes · Updated Sep 14, 2026 · NCT06064097

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07749586

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06592599

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Recruiting
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT06682442

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT03010150

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT06636734

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.